Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12620001191987
ACTRN12620001191987
Completed
未知

A Feasibility Study Examining the Safety and Efficacy of a Do-It-Yourself Artificial Pancreas; a Hybrid Closed loop Android Artificial Pancreas System (AndroidAPS) in Adults with Type 1 Diabetes

Baker Heart and Diabetes Institute0 sites20 target enrollmentNovember 10, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Baker Heart and Diabetes Institute
Enrollment
20
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 10, 2020
End Date
December 20, 2021
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Type 1 diabetes greater than or equal to 6 months duration
  • •Adults age greater than or equal to 18 years
  • •Insulin pump therapy greater than or equal to 6 months duration
  • •HbA1c less than 10\.0%

Exclusion Criteria

  • •Current use of real time CGM in the previous 3 months
  • •Hospitalization for severe hypoglycaemia or ketoacidosis in the past 6 months
  • •Chronic kidney disease (eGFR \< 45 mL/min/1\.73m2\)
  • •Planned international travel during the study period
  • •Oral hypoglycaemic agents or non insulin injectable agents within past 4 weeks

Outcomes

Primary Outcomes

Not specified

Similar Trials

Suspended
Phase 1
PD005
JPRN-jRCTs032180407Ikezawa Jun10
Suspended
Not Applicable
A feasibility study to assess the safety and efficacy of JenaValve for patients with severe aortic stenosis (AS).Aortic StenosisCardiovascular - Other cardiovascular diseases
ACTRN12616000717459JenaValve Technology, Inc.30
Completed
Not Applicable
A Feasibility Study to Assess Safety and Efficacy of the Transapical and Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients with Symptomatic Severe Aortic Stenosis (AS) (CA-0001)/ Symptomatic Severe Aortic Regurgitation (AR) (CA-0002)leaking heart valvenarrow heart valve10046973
NL-OMON46960JenaValve Technology, Inc.30
Suspended
Not Applicable
A feasibility study to assess the safety and efficacy of JenaValve for patients with severe aortic regurgitation (AR).
ACTRN12616000718448JenaValve Technology, Inc.15
Completed
Not Applicable
se of a Topical Skin Adhesive to close Wounds from Surgical IncisionsHealth Condition 1: null- Patients undergoing a planned elective CABG procedure (likely to have incision for saphenous vein harvesting) and have easily approximated skin edges of wounds from incisions.
CTRI/2017/06/008795Medical Adhesive Revolution GmbH10